{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:09Z","timestamp":1786120269690,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1097\/iae.0b013e31823496a3","type":"journal-article","created":{"date-parts":[[2011,10,19]],"date-time":"2011-10-19T04:24:19Z","timestamp":1318998259000},"page":"1395-1402","source":"Crossref","is-referenced-by-count":34,"title":["EFFECT OF INTRAVITREAL METHOTREXATE AND AQUEOUS HUMOR CYTOKINE LEVELS IN REFRACTORY RETINAL VASCULITIS IN BEHCET DISEASE"],"prefix":"10.1097","volume":"32","author":[{"given":"Jeong Hun","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20210130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.preteyeres.2007.09.002","article-title":". Behcets disease: ocular effects and treatment.","volume":"27","author":"Deuter","year":"2008","journal-title":"Prog Retin Eye Res"},{"key":"R2-23-20210130","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bjo.2004.054239","article-title":"The use of low dose methotrexate in children with chronic anterior and intermediate uveitis.","volume":"89","author":"Malik","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R3-23-20210130","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0161-6420(01)00576-0","article-title":"Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients.","volume":"108","author":"Samson","year":"2001","journal-title":"Ophthalmology"},{"key":"R4-23-20210130","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/archopht.1997.01100160322009","article-title":"Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.","volume":"115","author":"Fishburne","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"R5-23-20210130","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0161-6420(02)01125-9","article-title":". Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement.","volume":"109","author":"Smith","year":"2002","journal-title":"Ophthalmology"},{"key":"R6-23-20210130","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ajo.2006.06.002","article-title":". Intraocular methotrexate in ocular diseases other than primary central nervous system lymphoma.","volume":"142","author":"Hardwig","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R7-23-20210130","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ophtha.2008.10.033","article-title":"Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.","volume":"116","author":"Taylor","year":"2009","journal-title":"Ophthalmology"},{"key":"R8-23-20210130","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R9-23-20210130","doi-asserted-by":"crossref","first-page":"596","DOI":"10.47102\/annals-acadmedsg.V33N5p596","article-title":". Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcets disease.","volume":"33","author":"Akdeniz","year":"2004","journal-title":"Ann Acad Med Singapore"},{"key":"R10-23-20210130","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/art.20334","article-title":". Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behcets disease.","volume":"50","author":"Ben Ahmed","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R11-23-20210130","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1046\/j.1365-4362.2003.01688.x","article-title":". Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behcets syndrome.","volume":"42","author":"Cekmen","year":"2003","journal-title":"Int J Dermatol"},{"key":"R12-23-20210130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ajo.2006.04.016","article-title":"Intraocular cytokine environment in active Behcet uveitis.","volume":"142","author":"Ahn","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R13-23-20210130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/bjo.2007.127928","article-title":". Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.","volume":"92","author":"Frenkel","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R14-23-20210130","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1172\/JCI116884","article-title":"The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.","volume":"92","author":"Cronstein","year":"1993","journal-title":"J Clin Invest"},{"key":"R15-23-20210130","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/ar419","article-title":"Molecular action of methotrexate in inflammatory diseases.","volume":"4","author":"Chan","year":"2002","journal-title":"Arthritis Res"},{"key":"R16-23-20210130","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.4049\/jimmunol.153.9.4159","article-title":"Differential regulatory effects of adenosine on cytokine release by activated human monocytes.","volume":"153","author":"Bouma","year":"1994","journal-title":"J Immunol"},{"key":"R17-23-20210130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/1529-0131(199801)41:1<48::AID-ART7>3.0.CO;2-K","article-title":". Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction.","volume":"41","author":"Constantin","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R18-23-20210130","first-page":"532","article-title":"Endotoxin-induced uveitis in the rat. The significance of intraocular interleukin-6.","volume":"33","author":"Hoekzema","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R19-23-20210130","first-page":"1097","article-title":". Role of NF-kappaB-mediated interleukin-8 expression in intraocular neovascularization.","volume":"39","author":"Yoshida","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-23-20210130","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2230.2006.02157.x","article-title":"Serum substance P and calcitonin gene-related peptide levels in Behcets disease and their association with disease activity.","volume":"31","author":"Aki","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"R21-23-20210130","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood-2004-08-3178","article-title":"Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A.","volume":"105","author":"Hong","year":"2005","journal-title":"Blood"},{"key":"R22-23-20210130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0002-9394(01)01269-7","article-title":". Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema.","volume":"133","author":"Funatsu","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R24-23-20210130","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0002-9394(01)01103-5","article-title":". Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema.","volume":"132","author":"Fine","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R25-23-20210130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00024382-200115040-00008","article-title":". Adenosine inhibits neutrophil vascular endothelial growth factor release and transendothelial migration via A2B receptor activation.","volume":"15","author":"Wakai","year":"2001","journal-title":"Shock"},{"key":"R26-23-20210130","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/01.ATV.0000096208.80992.63","article-title":". Molecular mechanism and role of endothelial monocyte chemoattractant protein-1 induction by vascular endothelial growth factor.","volume":"23","author":"Yamada","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"pt 1","key":"R27-23-20210130","doi-asserted-by":"crossref","first-page":"C522","DOI":"10.1152\/ajpcell.1996.270.2.C522","article-title":"Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells.","volume":"270","author":"Bouma","year":"1996","journal-title":"Am J Physiol"},{"key":"R28-23-20210130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10792-009-9301-3","article-title":"A clinical approach to the diagnosis of retinal vasculitis.","volume":"30","author":"El-Asrar","year":"2010","journal-title":"Int Ophthalmol"},{"key":"R29-23-20210130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2990.2003.00499.x","article-title":"The pathology and pathogenesis of retinal vasculitis.","volume":"29","author":"Hughes","year":"2003","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R30-23-20210130","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1167\/iovs.05-0880","article-title":". Methotrexate reduces the complications of endophthalmitis resulting from intravitreal injection compared with dexamethasone in a rabbit model.","volume":"47","author":"Deng","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006982-201207000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:24:47Z","timestamp":1786047887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-201207000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e31823496a3","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}